A Randomized, Double-masked, Vehicle-controlled Study of LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2017
At a glance
- Drugs LME 636 (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Alcon
- 28 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Aug 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov